The potential of repurposing medications can revolutionize the treatment landscape for orphan diseases and improve patient outcomes.
The Coastal Program for Rare Inflammatory Diseases at Vancouver Coastal Health, led by Dr. Luke Chen, is building a collaborative network to accelerate treatments for patients with rare and orphan diseases through innovative, cost-effective drug repurposing strategies.
In partnership with the U.S.-based Every Cure organization, the program utilizes artificial intelligence and computational pharmacophenomics to identify existing medications that may treat rare diseases, reducing time and cost compared to traditional drug development.
Accelerating treatments for rare diseases through innovative strategies.
Author's summary: Repurposing medications improves rare disease treatment.